Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11135021 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
Condition: Migraine
Interventions: Drug: Sumatriptan/Naproxen Sodium;   Drug: Naproxen Sodium

Indicates status has not been verified in more than two years